INNERDYNE INC
SC 14D9/A, 2000-11-30
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: INNERDYNE INC, 425, 2000-11-30
Next: INNERDYNE INC, SC TO-T/A, 2000-11-30




    As filed with the Securities and Exchange Commission on November 30, 2000
================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 ---------------
                               AMENDMENT TO NO. 4
                                       TO
                                 SCHEDULE 14D-9
                                 (RULE 14D-101)

         SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14 (d) (4)
                     OF THE SECURITIES EXCHANGE ACT OF 1933

                                 ---------------

                                 INNERDYNE, INC.
                            (Name of Subject Company)

                                 INNERDYNE, INC.
                      (Name of Person(s) Filing Statement)


                                    45764D102
                      (CUSIP Number of Class of Securities)

                              1244 Reamwood Avenue
                               Sunnyvale, CA 94089
                                 (408) 745-6010
               (Address, including zip code, and telephone number,
                      including area code, of Registrant's
                          principal executive offices)

                                 ---------------

                                William G. Mavity
                      President and Chief Executive Officer
                                 InnerDyne, Inc.
                              1244 Reamwood Avenue
                               Sunnyvale, CA 94089
                                 (408) 745-6010
 (Name, Address and telephone Number of Person Authorized to Receive Notices and
           Communications on Behalf of the Person(s) Filing Statement)

                                 ---------------

                                    Copy to:
                              Alan Talkington, Esq.
                       Orrick, Herrington & Sutcliffe LLP
                               400 Sansome Street
                             San Francisco, CA 94111
                                 (415) 392-1122
                                 ---------------

|_|  Check the box if the filing relates  solely to  preliminary  communications
     made before the commencement of a tender offer.
================================================================================

<PAGE>

The purpose of this  Amendment  No. 4 is to amend and  supplement  Item 9 of the
Schedule  14D-9 as described  below.  Defined  terms used herein and not defined
have the meanings given them in the Schedule 14D-9 previously filed.


ITEM   9.         EXHIBITS.

Item 9 is amended and  supplemented as set forth below.  The remainder of Item 9
as previously filed is incorporated herein by reference.

(a)(9)     Joint Press Release of InnerDyne,  Inc. and Tyco International  Ltd.,
           dated November 30, 2000.

<PAGE>

                                    SIGNATURE

         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.

Dated:  November 30, 2000

                                          InnerDyne, Inc.


                                          By: /s/ William G. Mavity
                                             -----------------------------------
                                          Name:  William G. Mavity
                                          Title: President and Chief
                                                 Executive Officer


                                       2

<PAGE>

                                                                 EXHIBIT (a)(9)


FOR IMMEDIATE RELEASE
(Thursday, November 30, 2000)



CONTACTS:
TYCO:
Investor Relations                          Media Relations
J. Brad McGee                               Judith Czelusniak
Executive Vice President,                   Senior Vice President,
Chief Strategy Officer                      Corporate Relations
Tyco International (US) Inc.                Tyco International (US) Inc.
(603) 778-9700                              (561) 988-7424

INNERDYNE:
William G. Mavity
President/CEO
InnerDyne, Inc.
(408) 745-6010


                  SHARES ACCEPTED IN INNERDYNE EXCHANGE OFFER;
                       OFFER EXTENDED TO DECEMBER 1, 2000

Pembroke,  Bermuda and Sunnyvale,  CA,  November 30, 2000 -- Tyco  International
Ltd. (NYSE:  TYC; LSE: TYI; BSX: TYC), a diversified  manufacturing  and service
company,  and  InnerDyne,  Inc.  (NASDAQ:  IDYN),  a  medical  manufacturer  and
distributor  of  patented  radial  dilating  access  devices  used in  minimally
invasive surgical  procedures,  today announced that Tyco Acquisition Corp. X, a
subsidiary of Tyco, has accepted  tendered  shares for exchange in its offer for
the common stock of InnerDyne.

The exchange  ratio for the offer is 0.1337 Tyco common shares for each share of
InnerDyne  common stock.  This values InnerDyne common stock at $7.50 per share,
based upon an average  price for Tyco  common  shares  over a five  trading  day
period that ended on November 27, 2000.

Tyco Acquisition was advised by ChaseMellon  Shareholder Services,  the exchange
agent for the offer,  that,  as of 6:00 p.m. on November  29,  2000,  a total of
20,961,312  shares were tendered in

<PAGE>

the offer  (including  897,221 shares  through  notice of guaranteed  delivery),
which constitutes  approximately 89.9% of the total number of outstanding shares
of InnerDyne common stock.

Tyco and  InnerDyne  also  announced an extension of the exchange  offer for all
remaining common stock of InnerDyne to 6:00 p.m., New York City time, on Friday,
December  1, 2000.  All shares  tendered  during the  extension  period  will be
promptly  accepted for exchange at the 0.1337 exchange  ratio.  There will be no
withdrawal rights during the extension period.

As  soon  as  practicable  following  the  expiration  of the  offer  extension,
InnerDyne  will  be  merged  with  a  subsidiary  of  Tyco  and  will  become  a
wholly-owned Tyco subsidiary. If following the expiration of the offer extension
Tyco Acquisition has acquired at least 90% of the outstanding  InnerDyne shares,
the merger will be accomplished under Delaware's short-form merger procedure. In
the merger,  stockholders  will  receive the same  consideration  of 0.1337 Tyco
common  shares per share of InnerDyne  common stock as received by  stockholders
who tendered in the offer.

ABOUT INNERDYNE
InnerDyne designs,  develops and manufactures minimally invasive surgical access
products that incorporate the company's  proprietary radial dilation technology,
including  the patented  Step(TM)  expandable  needle  system.  Radial  dilation
provides  surgical  access  through  expansion  of a very  small  opening  using
progressively larger blunt instruments.

ABOUT TYCO INTERNATIONAL LTD.

Tyco International Ltd. is a diversified manufacturing and service company. Tyco
is the world's  largest  manufacturer  and servicer of electrical and electronic
components; the world's largest designer,  manufacturer,  installer and servicer
of  undersea  telecommunications  systems;  the  world's  largest  manufacturer,
installer  and  provider  of fire  protection  systems and  electronic  security
services; and the world's largest manufacturer of flow control valves. Tyco also
holds strong leadership  positions in disposable  medical  products,  diagnostic
imaging,  bulk  pharmaceuticals,  wound closure,  plastics and  adhesives.  Tyco
operates  in more than 100  countries  and has  reported  fiscal  2000  sales of
approximately $28.9 billion.


Tyco has filed a registration statement on Form S-4, a Schedule TO, a prospectus
and other  documents  relating to the exchange offer and InnerDyne has filed the
related  solicitation/recommendation  statement on Schedule  14D-9 with the SEC.
Copies of these  documents and other  documents filed by Tyco and InnerDyne with
the SEC may be  obtained  at the  SEC's  web site at  http://www.sec.gov.  These
documents may also be obtained from Tyco or from InnerDyne by directing requests
to Tyco International Ltd., The Zurich Centre,  Second Floor, 90 Pitts Bay Road,
Pembroke HM 08,  Bermuda,  tel:  (441)  292-8674;  or to InnerDyne,  Inc.,  1244
Reamwood Avenue, Sunnyvale, CA 94089, tel: (408) 745-6010.

Documents may also be obtained from MacKenzie  Partners,  Inc., the  information
agent for the offer, 156 Fifth Avenue,  New York, New York 10010, (212) 929-5500
(call collect) or (800) 322-2885 (toll free).




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission